Home Cart Sign in  
Chemical Structure| 109244-58-8 Chemical Structure| 109244-58-8

Structure of Dihydrorhodamine 123
CAS No.: 109244-58-8

Chemical Structure| 109244-58-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dihydrorhodamine 123 is a fluorescent probe (λex=488 nm, λem=525 nm).

Synonyms: DHR 123

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dihydrorhodamine 123

CAS No. :109244-58-8
Formula : C21H18N2O3
M.W : 346.38
SMILES Code : O=C(OC)C1=CC=CC=C1C2C3=C(OC4=C2C=CC(N)=C4)C=C(N)C=C3
Synonyms :
DHR 123
MDL No. :MFCD04221428
InChI Key :FNEZBBILNYNQGC-UHFFFAOYSA-N
Pubchem ID :105032

Safety of Dihydrorhodamine 123

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEI-OC1 cells 1 μM 30 min To assess changes in mitochondrial membrane potential, results showed cisplatin injury led to decreased mitochondrial membrane potential, while PRMT6 knockdown partially restored it. PMC6929624
Mouse primary cholangiocytes 100 μM 5 min To evaluate the multidrug resistance protein 1 (MDR1) transport function of cholangiocytes, results showed that rhodamine 123 was efficiently transported into bile duct-like structures in functional ductal organoids (FDOs). PMC10073412
HEI-OC1 cells 1 μM 30 min To assess mitochondrial membrane potential (MMP), results showed that Rhodamine 123 fluorescence intensity was significantly reduced after cisplatin treatment, and RG108 pretreatment reversed this effect. PMC9069410
Brain microvascular endothelial cells (BMEC) 10 μM 24 h Evaluation of P-glycoprotein (P-gp) efflux pump activity, showing significantly higher transport efficiency of Rhodamine 123 from basolateral-to-apical side compared to apical-to-basolateral side, indicating polarized expression of P-gp on the apical side. PMC9214798
Granulosa cells (GCs) 10 μM 30 min To measure mitochondrial membrane potential (MMP), results showed that CDDP significantly reduced MMP, while FER-1 pretreatment ameliorated this damage. PMC11401273
HUVECs 600 mg/mL 90 min To evaluate the permeability of Rhodamine 123 in BBB and BTB models, results showed significant increase in permeability in the presence of P-gp inhibitors. PMC5260004
Hippocampal neurons 2 µM To assess changes in mitochondrial membrane potential, results showed that ABPPs attenuated the glutamate-induced changes in mitochondrial membrane potential. PMC7034289
HeLa cells 0, 2.5, 5, 10, 20 μM 6 h To evaluate the effect of IVM on mitochondrial membrane potential, results showed that IVM treatment led to a gradual decrease in mitochondrial membrane potential. PMC6496724

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rat E19 fetal, P4, P14 and adult (6-10 week) rats Intraperitoneal injection 2.5-20 mg/kg Single injection, sampled 30 minutes post-injection To investigate R123 transfer from blood to brain and CSF at different developmental stages. Results showed higher R123 transfer into fetal and newborn rat brains (E19:43%, P4:43%, P14:22%, adult:9%), indicating developmental enhancement of BBB restriction capacity for PGP substrates. PMC7871379

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.89mL

0.58mL

0.29mL

14.44mL

2.89mL

1.44mL

28.87mL

5.77mL

2.89mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories